VI
RVNC

Vestcor Inc’s Revance Therapeutics, Inc. RVNC Stock Holding History

Vestcor Inc’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,428
Closed -$7K – 1316
2024
Q4 		$7K Buy
+2,428
New +$10.6K ﹤0.01% 1175

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vestcor Inc's RVNC Position: Q1 2025 in Review

Vestcor Inc sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 2,428 shares — an estimated $7K sold.

Vestcor Inc first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $7K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • Vestcor Inc reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • Vestcor Inc sold 2,428 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $7K.
  • Vestcor Inc first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
  • Vestcor Inc's Revance Therapeutics, Inc. position peaked at $7K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.